Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Westaim Biomedical

This article was originally published in The Tan Sheet

Executive Summary

Firm receives FDA clearance to market antimicrobial bandages for OTC use Feb. 21. Silver-based nanocrystalline coated bandage, a lower-dose version of Exeter, N.H.-based company's Acticoat burn and chronic wound dressings, is expected to reach market in about two years, firm says. New marketing clearance will allow Westaim to adapt technology to consumer products for local management of superficial wounds, cuts, scrapes, abrasions, lacerations and minor burns. Firm is seeking licensing partners among "the world's leading [OTC] bandage producers"

You may also be interested in...



J&J First Aid Advanced Care Premium OTC Wound Care Line Shipping Now

Johnson & Johnson Consumer Products is unveiling a premium-priced line of wound care products called First Aid Advanced Care, the company announced March 12.

J&J First Aid Advanced Care Premium OTC Wound Care Line Shipping Now

Johnson & Johnson Consumer Products is unveiling a premium-priced line of wound care products called First Aid Advanced Care, the company announced March 12.

J&J First Aid Advanced Care Premium OTC Wound Care Line Shipping Now

Johnson & Johnson Consumer Products is unveiling a premium-priced line of wound care products called First Aid Advanced Care, the company announced March 12.

Topics

UsernamePublicRestriction

Register

PS092246

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel